Corvus Pharmaceuticals
Earnings Surprise
Analysts estimated CRVS earnings of $-0.13 per share this quarter (Q4). CRVS's actual earnings were $-0.15 per share.
CRVS EPS surprise of -13.72%Analysts estimated CRVS earnings of $-0.14 per share this quarter (Q3). CRVS's actual earnings were $-0.12 per share.
CRVS EPS surprise of 11.83%Analysts estimated CRVS earnings of $-0.14 per share this quarter (Q2). CRVS's actual earnings were $-0.10 per share.
CRVS EPS surprise of 29.87%Analysts estimated CRVS earnings of $-0.12 per share this quarter (Q1). CRVS's actual earnings were $0.21 per share.
CRVS EPS surprise of 273.27%Analysts estimated CRVS earnings of $-0.12 per share this quarter (Q4). CRVS's actual earnings were $-0.18 per share.
CRVS EPS surprise of -47.54%Analysts estimated CRVS earnings of $-0.12 per share this quarter (Q3). CRVS's actual earnings were $-0.60 per share.
CRVS EPS surprise of -404.63%Analysts estimated CRVS earnings of $-0.12 per share this quarter (Q2). CRVS's actual earnings were $-0.04 per share.
CRVS EPS surprise of 65.90%Analysts estimated CRVS earnings of $-0.14 per share this quarter (Q1). CRVS's actual earnings were $-0.12 per share.
CRVS EPS surprise of 12.85%Analysts estimated CRVS earnings of $-0.12 per share this quarter (Q3). CRVS's actual earnings were $-0.12 per share.
CRVS EPS surprise of -3.54%Analysts estimated CRVS earnings of $-0.12 per share this quarter (Q3). CRVS's actual earnings were $-0.12 per share.
CRVS EPS surprise of -3.54%